Health Technology Assessment of Advanced Therapy Medicinal Products: Comparison Among 3 European Countries
Even for centrally approved products, each European country is responsible for the effective national market access. This step can result in inequalities in terms of access, due to different opinions about the therapeutic value assessed by health technology assessment (HTA) bodies. Advanced therapy...
Saved in:
Main Authors: | Lucia Gozzo (Author), Giovanni Luca Romano (Author), Francesca Romano (Author), Serena Brancati (Author), Laura Longo (Author), Daniela Cristina Vitale (Author), Filippo Drago (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2021-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The therapeutic value of treatment for multiple sclerosis: analysis of health technology assessments of three European countries
by: Lucia Gozzo, et al.
Published: (2023) -
Access to Innovative Neurological Drugs in Europe: Alignment of Health Technology Assessments Among Three European Countries
by: Lucia Gozzo, et al.
Published: (2022) -
Dexamethasone Treatment for Covid-19, a Curious Precedent Highlighting a Regulatory Gap
by: Lucia Gozzo, et al.
Published: (2020) -
The Regulatory Challenges for Drug Repurposing During the Covid-19 Pandemic: The Italian Experience
by: Lucia Gozzo, et al.
Published: (2020) -
The Potential Role of Heparin in Patients With COVID-19: Beyond the Anticoagulant Effect. A Review
by: Lucia Gozzo, et al.
Published: (2020)